Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectGlobal Market for Centrifugation in Life Sciences Industry
The global market for centrifugation in life sciences should grow from $3.5 billion in 2021 to $5.1 billion by 2026, at compound annual growth rate (CAGR) of 7.6% for the period of 2021-2026.
Digital Biomarkers: Global Markets
The global market for digital biomarkers should grow from $1.8 billion in 2021 to $7.2 billion by 2026, at compound annual growth rate (CAGR) of 31.6% for the period of 2021-2026.
2021 Biotechnology Research Review
BCC Research Market Report says bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4%.
Synthetic Biology: Global Markets
The global market for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate (CAGR) of 28.4% during the forecast period of 2021-2026.
DNA Repair Drugs: Global Markets
The global DNA repair drugs market should reach $19.5 billion by 2026 from $7.5 billion in 2021 at a compound annual growth rate (CAGR) of 21.0% for the forecast period of 2021 to 2026.
Protein Sequencing: Global Market
The global market for protein sequencing should grow from $1.3 billion in 2021 to $1.6 billion by 2026 with a compound annual growth rate (CAGR) of 4.6% for the period of 2021-2026.
Biobanking: Technologies and Global Markets
The global market for biobanking is estimated to increase from $61.1 billion in 2021 to $76.2 billion by 2026, at a compound annual growth rate (CAGR) of 4.5% during 2021-2026.
Global Cell and Gene Therapy Market
The global market for cell and gene therapy should grow from $4.1 billion in 2021 to $17.4 billion by 2026 with a compound annual growth rate (CAGR) of 33.6% for the period of 2021-2026.
Therapeutics for Women's Health: Technologies and Global Markets
The global market for women’s health therapeutics should grow from $54.4 billion in 2021 to $70.8 billion by 2026 with a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
Cancer Stem Cells: Technologies and Global Markets
The global market for cancer stem cells should grow from $2.1 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate (CAGR) of 16.1% for the period of 2021-2026.
Current Research & Development Status of Chimeric Antigen Recepto...
The global market for chimeric antigen receptor (CAR) T-cell therapy is estimated to grow from $1.5 billion in 2021 to reach $7.6 billion by 2026, at a compound annual growth rate (CAGR) of 39.1% during 2021-2026.
Exosome Diagnostics and Therapeutics: Global Markets
The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.
Metabolomics: Technologies and Global Markets
The global metabolomics market should reach $22.7 billion by 2026 from $12.7 billion in 2021 at a compound annual growth rate (CAGR) of 12.3% for the forecast period of 2021 to 2026.
Antibody Drugs: Technologies and Global Markets
The global market for antibody drugs should grow from $126.7 billion in 2021 to $208.6 billion by 2026 with a compound annual growth rate (CAGR) of 10.5% for the period of 2021-2026.
Cell Separation Techniques - Magnetic and Flow-Based Models: Glob...
The global cell separation techniques market should reach $4.4 billion by 2026 from $3.1 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026.
The U.S. Market for Biodefense-Related Rapid Pathogen Identificat...
The U.S. biodefense-related rapid pathogen identification and treatment market should reach $518.3 million by 2026 from $366.3 million in 2021 at a compound annual growth rate (CAGR) of 7.2% for the forecast period of 2021 to 2026.
RNA Analysis Market
The global market for RNA analysis/transcriptomics should grow from $8.3 billion in 2021 to $13.4 billion by 2026, at compound annual growth rate (CAGR) of 9.9% for the period of 2021-2026.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology is estimated to grow from $5.0 billion in 2021 to $7.4 billion by 2026 at a compound annual growth rate (CAGR) of 7.9% of during the forecast period of 2021-2026.
Biological Therapies for Cancer: Technologies and Global Markets
The global cancer biologics market should reach $143.0 billion by 2026 from $77.5 billion in 2021 at a compound annual growth rate (CAGR) of 13.0% for the forecast period of 2021 to 2026.
mRNA: Therapeutics and Global Markets
The global market for mRNA therapeutics should grow from $46.7 billion in 2021 to $101.3 billion by 2026, at compound annual growth rate (CAGR) of 16.8% for the period of 2021-2026.
Oligonucleotides: Global Markets to 2026
The global market for oligonucleotide synthesis should grow from $6.1 billion in 2021 to $10.2 billion by 2026 with a compound annual growth rate (CAGR) of 10.7% for the period of 2021-2026.
Polymerase Chain Reaction (PCR) Technologies and Global Markets
The global market for PCR technology should grow from $10.5 billion in 2021 to $13.7 billion by 2026, at compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
High Content Screening/Imaging: Technologies and Global Markets
The global market for high content screening/imaging technology should grow from $1.2 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 13.5% for the period of 2021-2026.
DNA Vaccines: Technologies and Global Markets
The global market for DNA vaccines should grow from $3.1 billion in 2021 to $11.5 billion by 2026 with a compound annual growth rate (CAGR) of 30.1% for the period of 2021-2026.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market should reach $394.2 billion by 2026 from $265.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.
Choose your License
Biologics Contract Development and Manufacturing Organizations (CDMO) Market
- An up-to-date overview and industry analysis of the global markets for biologics contract development and manufacturing organizations (CDMO)
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for biologics CDMO market in USD million values, and their corresponding market share analysis based on the product type, cell line type, and geographic region
- In-depth information (facts and figures) concerning the market growth drivers, opportunities and challenges, prospects, technologies, regulatory scenarios, and the impact of macroeconomic variables on biologics CDMO marketplace
- Discussion of ESG developments in global CDMO services market, with emphasis on importance of ESG, consumer attitudes, risks and opportunity assessment, and ESG followed practices
- Identification of the pharma companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
- Market outlook and opportunity assessment of the industry structure for biologics CDMO services, and evaluation of ongoing clinical trials and R&D activities estimating current and future market demand
- Insight into the growth development strategies of the key market players operating within the global market; their key competitive landscape and company share analysis
- Analysis of the company competitive landscape based on recent developments, key financials, and operational integration
- Descriptive company profiles of the major market players
Bioinformatics: Technologies and Global Markets
- An up-to-date overview and industry analysis of the global bioinformatics market
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for global bioinformatics market in USD million values, and corresponding market share analysis based on the type of sequencing services and platforms, application, solution, end user, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
- Coverage of information on the latest developments in the bioinformatics tools and services market, innovations in bioinformatics solutions for drug discovery, and details of antibody-based drug discovery and developments
- Impact analysis of various region specific and industry specific macroeconomic variables on global bioinformatics market
- Identification of the innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
- Understanding of the importance of ESG in the market for bioinformatics tools and services, consumer attitudes towards sustainability, risks & opportunity assessment, ratings and matrices, and ESG practices in global bioinformatics marketplace
- A look at the major vendors in the global bioinformatics market, and analyze the structure of this industry with respect to company market shares, venture fundings, and recent M&A activities
- Patent analysis covering significant allotments of recent patent grants across each major category
- Profile descriptions of the leading market players
Agricultural Biotechnology: Emerging Technologies and Global Markets
- An overview of the global markets for agricultural biotechnology and other emerging technologies
- Estimation of the market size and analyses of global market trends with data from 2022, 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Description of key agricultural biotechnology tools such as next generation DNA sequencing, biochips, RNA interference, synthetic biology tools and genome editing tools, and assaying their role in enhancing the marketplace
- Assessment of market opportunities for biotechnology tools, genomic-enabled products, and biotech seeds
- Key merger and acquisitions, joint ventures, and alliances within the large biotechnology companies, allowing them to participate in the upside of new genomics technologies that will enhance their breeding, seed development, and biologics programs
- Company profiles of market leading participants
Digital Polymerase Chain Reaction (PCR) Technology: Global Markets
- An up-to-date overview and industry analysis of the global market for digital polymerase chain reaction (PCR) technology
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for digital PCR technologies market, and corresponding market share analysis based on product, technology type, application, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
- Discussion of industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on manufacturers, suppliers, and major types of end-users
- Analysis of the market growth opportunities with a holistic review of Porter’s five forces analysis and PESTLE analysis considering both micro- and macro environmental factors prevailing in marketplace
- Understanding of the importance of ESG in the digital PCR technology market, consumer attitudes, risks and opportunity assessment, and ESG followed practices by manufacturers and service providers
- A look at the major vendors in the global market for digital PCR technologies, and analyze the structure of the industry (e.g., market shares, concentration, and recent M&A activities)
- Identification of the major stakeholders and analysis of their company competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
- Detailed company profiles of the leading market players
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
- An overview of the global market for emerging clinical applications of the next-generation sequencing
- Estimation of the market size and analyses of global market trends with data from 2022, 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Highlights of the current and future market potential and quantification of the market by disease indication, test complexity, test purpose, application, and geographic region
- Discussion on market opportunities for clinical NGS products, clinical applications, industry structure, regulatory scenario, and penetration of NGS-based diagnostics and technologies within the industry
- Coverage of genome mapping programs, discussion on technological advancements and innovations in sequencing platforms, and information on Ion Torrent Genexus System launched by Thermo Fisher Scientific and Magnis NGS Prep System launched by Agilent Technologies, Inc.
- Description of NGS-oriented tests such as non-invasive prenatal testing (NIPT), and pre-implantation genetic testing (PGT) and discussion on their advantages
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry
Induced Pluripotent Stem Cells: Global Markets
- An overview of the global market for induced pluripotent stem cells
- Estimation of the market size and analyses of market trends, with data from 2022, estimates for 2023 and projection of CAGR through 2028
- Analysis of the market's dynamics, including growth drivers, inhibitors, and opportunities, and insights into the regulatory environments impacting the market
- Assessment of recent or ongoing research and development activities in the iPSCs segment, highlights of the new developments and the recent pipeline products
- Information on the latest research activities, emerging technologies, and clinical trials
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry
Global Markets for Research Antibodies
- An overview of the global market landscape related to the research antibodies
- In-depth analysis of global market trends, featuring historical revenue data for 2022, estimated figures for 2023, as well as forecasts for 2023 and 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by product, clonality, application, end-user, and geographical region
- Discussion on the factors affecting the companies’ market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
- Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
- Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
- Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry’s growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
- Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses